Vancomycin Hychloride



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 25.8%
Pneumonia Staphylococcal 7.9%
Endocarditis 6.7%
Pneumonia 6.7%
Cardiac Failure 4.5%
Cellulitis 4.5%
Infection 4.5%
Pulmonary Hypertension 4.5%
Staphylococcal Infection 4.5%
Antibiotic Prophylaxis 3.4%
Immunosuppression 3.4%
Pain 3.4%
Paraspinal Abscess 3.4%
Pyrexia 3.4%
Anaemia 2.2%
Antibiotic Resistant Staphylococcus Test Positive 2.2%
Cardiac Disorder 2.2%
Cardiac Failure Congestive 2.2%
Nerve Block 2.2%
Staphylococcal Sepsis 2.2%
Drug Hypersensitivity 11.4%
Drug Rash With Eosinophilia And Systemic Symptoms 11.4%
No Adverse Event 11.4%
Death 8.6%
Leukocytoclastic Vasculitis 5.7%
Pain 5.7%
Papule 5.7%
Red Man Syndrome 5.7%
Abdominal Discomfort 2.9%
Abdominal Sepsis 2.9%
Acute Myocardial Infarction 2.9%
Anaemia 2.9%
Bronchospasm 2.9%
Cholangitis 2.9%
Deafness 2.9%
Drug Interaction 2.9%
Drug Level Increased 2.9%
Erythema 2.9%
Face Oedema 2.9%
Flushing 2.9%
Secondary
Product Used For Unknown Indication 16.1%
Adult T-cell Lymphoma/leukaemia 13.8%
Pulmonary Hypertension 6.9%
Urinary Tract Infection 6.1%
Osteitis 5.7%
Staphylococcal Infection 5.7%
Skin Ulcer 5.4%
Anaemia 4.6%
Cardiac Failure Congestive 4.6%
Endocarditis 4.6%
Antibiotic Therapy 3.8%
Prophylaxis 3.4%
Antifungal Prophylaxis 2.7%
Meningitis 2.7%
Pneumonia 2.7%
Constipation 2.3%
Life Support 2.3%
Pneumonia Staphylococcal 2.3%
Polyuria 2.3%
Gastric Ulcer Haemorrhage 1.9%
Urine Output Decreased 12.8%
Drug Rash With Eosinophilia And Systemic Symptoms 10.6%
Toxic Epidermal Necrolysis 8.5%
Tubulointerstitial Nephritis 8.5%
Drug Hypersensitivity 6.4%
Renal Disorder 6.4%
Drug Effect Decreased 4.3%
Face Oedema 4.3%
Hepatic Function Abnormal 4.3%
Hepatocellular Injury 4.3%
Human Herpes Virus 6 Serology Positive 4.3%
Interstitial Lung Disease 4.3%
Leukopenia 4.3%
Septic Shock 4.3%
Acute Generalised Exanthematous Pustulosis 2.1%
Acute Respiratory Distress Syndrome 2.1%
Anaemia 2.1%
Aphasia 2.1%
Back Pain 2.1%
Basedow's Disease 2.1%
Concomitant
Product Used For Unknown Indication 29.9%
Infection Prophylaxis 13.7%
Prophylaxis 9.4%
Prophylaxis Against Graft Versus Host Disease 6.8%
Bone Marrow Conditioning Regimen 6.4%
Sepsis 3.5%
Acute Myeloid Leukaemia 3.3%
Antifungal Prophylaxis 3.0%
Premedication 2.6%
Acute Lymphocytic Leukaemia 2.6%
Electrolyte Substitution Therapy 2.4%
Pain 2.2%
Hypertension 2.1%
Antibiotic Prophylaxis 2.0%
Interstitial Lung Disease 2.0%
Febrile Neutropenia 1.8%
Constipation 1.7%
Graft Versus Host Disease 1.7%
Cardiac Failure 1.5%
Disseminated Intravascular Coagulation 1.4%
Acute Graft Versus Host Disease In Skin 7.8%
Gastrointestinal Perforation 7.8%
Hepatic Infection Fungal 7.8%
Hypokalaemia 7.8%
White Blood Cell Count Decreased 7.8%
Vomiting 5.9%
Anuria 3.9%
Bacterial Sepsis 3.9%
Cardiac Failure Congestive 3.9%
Cardiomyopathy 3.9%
Colitis 3.9%
Crohn's Disease 3.9%
Cystitis Haemorrhagic 3.9%
Decreased Appetite 3.9%
Disseminated Intravascular Coagulation 3.9%
Engraft Failure 3.9%
Hypertension 3.9%
Injury 3.9%
Pneumonia 3.9%
Pneumonia Cytomegaloviral 3.9%
Interacting
Localised Infection 22.2%
Subcutaneous Abscess 22.2%
Wound Infection 22.2%
Depression 11.1%
Restless Legs Syndrome 11.1%
Sleep Disorder 11.1%
Drug Interaction 42.9%
Nephropathy Toxic 28.6%
Hypokalaemia 14.3%
Staphylococcal Infection 14.3%